Animals as bioreactors ? the future of pharmaceutical industry?
Languages of publication
Biotechnology products and its application raise many controversies. Discussions are carried out where the supporters of GMO are underlining the qualities of genetically modified organisms, and sceptics are pointing the dangers that, in their perspective, are exceeding the benefits. In this article, we intend to show the qualities resulting from the use of transgenic animals to produce cheaper drugs, as biotechnology and genetic engineering methods gave the possibility to use animals as bioreactors.
Publication order reference
Agata Tyczewska, Instytut Chemii Bioorganicznej, Polska Akademia Nauk, ul. Noskowskiego 12/14, 61-704 Poznan, Poland